BINDREN

This brand name is authorized in Estonia

Active ingredients

The drug BINDREN contains one active pharmaceutical ingredient (API):

1 Colestilan UNII VSI302RYSR - COLESTILAN CHLORIDE

Colestilan is a non-absorbed, non-calcium, non-metallic phosphate-binding polymer. The binding sites become partially protonated in the stomach and interact through ionic and hydrogen bonding with both dietary phosphate anions and bile acids in the duodenum. By binding phosphate from food in the digestive tract, colestilan lowers the serum phosphorus concentration. Colestilan also binds bile acids, thereby lowering the serum LDL-cholesterol concentration. Read about Colestilan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BINDREN Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AE06		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1605664, 1605675, 1605686, 1605697, 1605709, 1605710, 1605721, 1605732, 1605743, 1605754, 1605765